IOL Chemicals & Pharmaceuticals has received a communication from US Food & Drug Administration (USFDA) with respect to an inspection conducted by USFDA of Ibuprofen manufacturing facilities located at Trident Complex, Barnala in the state of Punjab from August 05, 2019 to August 09, 2019. USFDA has concluded that inspection is ‘closed’ under 21 CFR part 20.64(d)(3).
IOL Chemicals & Pharmaceuticals is a leading organic chemicals manufacturer and supplier in India.